Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:CBKCVE:DWSNASDAQ:TLX On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCBKChristopher & Banks$0.31$0.31▼$1.16$12K2.66183,908 shsN/ADWSDiamond Estates Wines & SpiritsC$0.19+2.8%C$0.18C$0.15▼C$0.45C$11.01M1.9430,191 shs1,026 shsTLXTelix Pharmaceuticals Limited American Depositary Shares$16.25-5.4%$17.08$13.61▼$30.36$5.49BN/A27,431 shs35,873 shs10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCBKChristopher & Banks0.00%0.00%0.00%0.00%0.00%DWSDiamond Estates Wines & Spirits0.00%0.00%+5.71%-5.13%-2.63%TLXTelix Pharmaceuticals Limited American Depositary Shares-5.41%-12.59%-2.40%-7.88%+1,624,999,900.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCBKChristopher & BanksN/AN/AN/AN/AN/AN/AN/AN/ADWSDiamond Estates Wines & SpiritsN/AN/AN/AN/AN/AN/AN/AN/ATLXTelix Pharmaceuticals Limited American Depositary SharesN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCBKChristopher & Banks 0.00N/AN/AN/ADWSDiamond Estates Wines & Spirits 0.00N/AN/AN/ATLXTelix Pharmaceuticals Limited American Depositary Shares 3.00Buy$22.0035.38% UpsideCurrent Analyst Ratings BreakdownLatest CBK, TLX, DWS, and DB1 Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/12/2025TLXTelix Pharmaceuticals Limited American Depositary SharesWilliam BlairSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform(Data available from 5/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCBKChristopher & Banks$348.90M0.00N/AN/A$0.53 per share0.00DWSDiamond Estates Wines & SpiritsC$26.77M0.41N/AN/AC$0.39 per share0.47TLXTelix Pharmaceuticals Limited American Depositary Shares$783.21M7.01N/AN/AN/A∞Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCBKChristopher & Banks-$32.84M-$0.74N/AN/AN/A-9.41%-79.27%-26.01%N/ADWSDiamond Estates Wines & Spirits-C$10.21M-C$0.25N/A∞N/A-38.13%-52.53%-4.63%N/ATLXTelix Pharmaceuticals Limited American Depositary SharesN/AN/A0.0033.85N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCBKChristopher & BanksN/AN/AN/AN/AN/ADWSDiamond Estates Wines & SpiritsN/AN/AN/AN/AN/ATLXTelix Pharmaceuticals Limited American Depositary SharesN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCBKChristopher & BanksN/A1.180.34DWSDiamond Estates Wines & Spirits122.170.900.11TLXTelix Pharmaceuticals Limited American Depositary SharesN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCBKChristopher & Banks26.11%DWSDiamond Estates Wines & SpiritsN/ATLXTelix Pharmaceuticals Limited American Depositary SharesN/AInsider OwnershipCompanyInsider OwnershipCBKChristopher & Banks16.90%DWSDiamond Estates Wines & Spirits63.16%TLXTelix Pharmaceuticals Limited American Depositary SharesN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCBKChristopher & Banks3,70038.33 millionN/ANot OptionableDWSDiamond Estates Wines & Spirits10959.52 millionN/ANot OptionableTLXTelix Pharmaceuticals Limited American Depositary SharesN/A337.88 millionN/AN/ACBK, TLX, DWS, and DB1 HeadlinesRecent News About These CompaniesTelix FAP-targeting Therapeutic Published in Thyroid Journal: Demonstrates Encouraging EfficacyMay 7, 2025 | globenewswire.comShareholders that Lost Money on Telix Pharmaceuticals Limited (TLX) Should Contact Levi & Korsinsky About Securities Fraud Investigation - TLXMay 7, 2025 | accessnewswire.comATTENTION Telix Pharmaceuticals Limited Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your RightsMay 6, 2025 | accessnewswire.comTelix Pharmaceuticals Limited INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Telix Pharmaceuticals Limited (TLX)May 5, 2025 | accessnewswire.comTelix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Shares Gap Up - Still a Buy?May 5, 2025 | marketbeat.comTelix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Shares Gap Up - Time to Buy?May 4, 2025 | americanbankingnews.comTelix Pharmaceuticals Limited INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Telix Pharmaceuticals Limited (TLX)May 2, 2025 | accessnewswire.comTelix Pharmaceuticals Limited American Depositary Shares (TLX)May 1, 2025 | nasdaq.comTLX STOCK ALERT: Levi & Korsinsky Notifies Telix Pharmaceuticals Limited Investors of an Ongoing InvestigationMay 1, 2025 | accessnewswire.comWhat is William Blair's Estimate for TLX FY2026 Earnings?May 1, 2025 | marketbeat.comTelix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Shares Gap Down - What's Next?April 30, 2025 | marketbeat.comTLX ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Telix Pharmaceuticals LimitedApril 30, 2025 | accessnewswire.comTelix's Illuccix PSMA-PET Imaging Agent Approved in FranceApril 28, 2025 | globenewswire.comLevi & Korsinsky Announces an Investigation on Behalf of Telix Pharmaceuticals Limited (TLX) Shareholders Who May Have Been Affected by FraudApril 28, 2025 | accessnewswire.comTelix shares crash 8% on US FDA blowApril 27, 2025 | msn.comTelix Pharmaceuticals Ltd. ADRApril 23, 2025 | wsj.comTelix Reports US$186M Q1 Revenue, Up 62% YOYApril 22, 2025 | globenewswire.comIPAX-Linz Study Reports Promising Efficacy for TLX101 Glioma Therapy CandidateApril 15, 2025 | globenewswire.comAll You Need to Know About Telix Pharmaceuticals Limited (TLX) Rating Upgrade to BuyApril 14, 2025 | zacks.comTelix Shares May Gain on the Distribution Deal With Cardinal HealthApril 9, 2025 | zacks.comTelix Announces Cardinal Health for Gozellix Commercial DistributionApril 8, 2025 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCBK, TLX, DWS, and DB1 Company DescriptionsChristopher & Banks NYSE:CBKChristopher & Banks Corporation, through its subsidiaries, operates as a specialty retailer of private-brand women's apparel and accessories in the United States. The company designs and sells women's apparel and accessories to customers ranging in age from 40 and older. Its stores offer women's apparel consisting of casual clothing, everyday basics, wear-to-work, leisure/active wear, and sleepwear in missy, petite, and women sizes, as well as jewelry and accessories. As of December 4, 2018, the company operated 461 stores, including 314 MPW stores, 80 Outlet stores, 35 Christopher & Banks stores, and 32 stores in its women's plus size clothing division CJ Banks in 45 states. It also operates christopherandbanks.com, an e-commerce Website for its Christopher & Banks and CJ Banks brands. The company was formerly known as Braun's Fashions Corporation and changed its name to Christopher & Banks Corporation in July 2000. Christopher & Banks Corporation was founded in 1956 and is headquartered in Plymouth, Minnesota.Diamond Estates Wines & Spirits CVE:DWSC$0.18 +0.01 (+2.78%) As of 05/9/2025 09:30 AM EasternDiamond Estates Wines & Spirits Inc. produces, markets, distributes, and sells wines in Canada, China, and internationally. The company operates in two segments, Manufactured Wines and Agency. It produces VQA wines under the 20 Bees, Creekside, EastDell, Lakeview Cellars, Mindful, Shiny Apple Cider, Fresh, Red Tractor, Seasons, Serenity, D'Ont Poke the Bear, and Backyard Vineyards brand names. The company also sells its products through liquor boards, licensed restaurants and bars, grocery chains, direct-to-consumer, and retail stores, as well as acts as a sales agent for beverage alcohol brands. Diamond Estates Wines & Spirits Inc. was founded in 1999 and is based in Niagara-on-the-Lake, Canada.Telix Pharmaceuticals Limited American Depositary Shares NASDAQ:TLX$16.25 -0.93 (-5.41%) Closing price 05/12/2025 04:00 PM EasternExtended Trading$15.76 -0.49 (-3.02%) As of 05/12/2025 07:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Telix Pharmaceuticals Limited. engages in the development and commercialization of several clinical-stage oncology assets. It operates through the following segments: Commercial, Product Development, and Group and Unallocated. The Commercial segment includes sales of Illuccix and other products subsequent to obtaining regulatory approvals. The Product Development segment develops radiopharmaceutical products for commercialization. It focuses on cancer care, specifically in prostate, renal or kidney and glioblastoma or brain cancer. Its products include TLX250, TLX591, and TLX101. The company was founded by Andreas Kluge and Christian P. Behrenbruch in November 2015 and is headquartered in Melbourne, Australia. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Palantir’s Latest Deal Could Put a Freeze on Its Stock Price A 90-Day Tariff Pause Sends Alibaba Flying—BlackRock Was Ready BP Buyout Buzz Puts Spotlight on Transocean’s Comeback Potential Here's Why Call Option Traders Love Dutch Bros Stock Can Shopify Stock Make a Comeback After an Earnings Sell-Off? MarketBeat Week in Review – 05/05 - 05/09 Taiwan Semiconductor Has a New Reason to Rally on Chip Curbs 5 Reasons the Rebound in Microchip Technology Stock Is Real Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
